Bromfenac PCD Pharma Franchise Company

Cafoli Lifecare offers a Bromfenac range of 3 ophthalmic and otic drop formulations, manufactured in WHO-GMP certified facilities. Distributors serving ophthalmology and ENT prescribers can secure district-wise monopoly franchise rights for this modern NSAID drop with full promotional support.

What is Bromfenac?

Bromfenac is a non-steroidal anti-inflammatory drug (NSAID) formulated for topical ophthalmic use. It inhibits cyclo-oxygenase to reduce ocular inflammation and pain, and its potency allows convenient low-frequency dosing. It is widely used to control inflammation and pain after cataract and other eye surgery. Reference: PubChem - Bromfenac.

Available Forms

The Cafoli Bromfenac portfolio is offered as Eye Drops and Ear Drops for topical anti-inflammatory use. Contact us for current pack presentations and combinations.

Therapeutic Applications

Bromfenac eye drops are used to treat postoperative ocular inflammation and pain following cataract surgery, and to manage other inflammatory eye conditions. Prescribers are chiefly ophthalmologists and eye surgeons, with ENT specialists for otic use.

Why Bromfenac is a High-Potential Molecule for Distributors

India performs a very high and rising volume of cataract surgeries, and a topical NSAID like bromfenac is standard in the postoperative regimen of virtually every cataract case. Its low-frequency dosing makes it a preferred surgeon choice, so a distributor tied to busy eye hospitals and cataract camps gains steady, procedure-linked demand that few competitors service.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Bromfenac
2. PubMed: bromfenac in postoperative ocular inflammation
3. MedlinePlus: Bromfenac ophthalmic